Cytek Biosciences Ownership | Who Owns Cytek Biosciences?


OverviewForecastRevenueFinancialsChartTranscripts

Cytek Biosciences Ownership Summary


Cytek Biosciences is owned by 58.17% institutional investors, 8.80% insiders, and 33.03% retail investors. Blackrock is the largest institutional shareholder, holding 13.04% of CTKB shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.29% of its assets in Cytek Biosciences shares.

CTKB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCytek Biosciences58.17%8.80%33.03%
SectorHealthcare Stocks 46.98%7.90%45.12%
IndustryMedical Device Stocks50.53%7.92%41.55%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock17.07M13.04%$95.25M
Vanguard group11.75M8.97%$65.54M
Brown capital management11.39M8.70%$63.54M
Hhlr advisors6.66M5.08%$37.15M
State street3.97M3.03%$22.17M
New york state common retirement fund2.95M2.25%$16.45M
Geode capital management2.58M1.97%$14.39M
Wellington management group llp2.14M1.63%$11.92M
Dimensional fund advisors lp1.47M1.12%$8.17M
Goldman sachs group1.36M1.04%$7.57M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Brown capital management11.39M1.28%$63.54M
Hhlr advisors6.66M0.92%$37.15M
Algert global295.27K0.05%$1.65M
Sherbrooke park advisers29.98K0.03%$167.31K
Versor investments lp22.40K0.02%$124.99K
State of wyoming23.87K0.02%$133.20K
Dark forest capital management lp21.10K0.02%$117.73K
New york state common retirement fund2.95M0.02%$16.45M
Connor, clark & lunn investment management631.47K0.01%$3.52M
Dynamic technology lab private23.47K0.01%$131.00K

Top Buyers

HolderShares% AssetsChange
Millennium management946.49K0.00%919.85K
Goldman sachs group1.36M0.00%793.24K
Wellington management group llp2.14M0.00%780.74K
Jpmorgan chase608.44K0.00%523.03K
Renaissance233.90K0.00%233.90K

Top Sellers

HolderShares% AssetsChange
Ra capital management---6.81M
Brown capital management11.39M1.28%-634.63K
Divisadero street capital management, lp---487.55K
Blackrock17.07M0.00%-355.55K
Vanguard group11.75M0.00%-266.63K

New Positions

HolderShares% AssetsChangeValue
Renaissance233.90K0.00%233.90K$1.31M
Deerfield management company, l.p. (series c)155.76K0.01%155.76K$869.13K
Trexquant investment lp138.39K0.01%138.39K$772.24K
Corebridge financial69.33K0.00%69.33K$386.86K
Mirae asset global etfs61.83K0.00%61.83K$344.99K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-24.00
Kbc group nv-3.88K
Metropolitan life insurance co/ny-6.52K
Group one trading-8.38K
Two sigma investments, lp-13.21K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241263.28%76,150,225-5.51%581.64%7517.19%4014.29%
Mar 31, 202412219.61%80,592,4742.10%591.77%6412.28%3516.67%
Dec 31, 2023102-5.56%78,933,9201.89%571.78%57-20.83%3030.43%
Sep 30, 20231083.85%77,471,0300.55%561.76%72-2.70%2327.78%
Jun 30, 20231040.97%77,049,32112.47%562.22%7427.59%18-45.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF6.82M5.29%7.15K
Brown Capital Mgmt Small Co Inv3.90M2.96%-652.87K
Vanguard Total Stock Mkt Idx Inv3.47M2.64%-
iShares Russell 2000 ETF3.12M2.42%-7.01K
Vanguard Small Cap Index2.64M2.01%-16.23K
Vanguard Institutional Extnd Mkt Idx Tr1.54M1.17%-1.76K
Vanguard Small Cap Growth Index Inv1.45M1.10%-25.29K
Fidelity Small Cap Index1.24M0.94%-31.21K
iShares Russell 2000 Value ETF1.15M0.89%-
iShares S&P Small-Cap 600 Value ETF1.11M0.86%1.08K

Recent Insider Transactions


DateNameRoleActivityValue

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2-3
2024 Q1-2
2023 Q4-8
2023 Q3-9

CTKB Ownership FAQ


Who Owns Cytek Biosciences?

Cytek Biosciences shareholders are primarily institutional investors at 58.16%, followed by 8.80% insiders and 33.03% retail investors. The average institutional ownership in Cytek Biosciences's industry, Medical Device Stocks, is 50.53%, which Cytek Biosciences exceeds.

Who owns the most shares of Cytek Biosciences?

Cytek Biosciences’s largest shareholders are Blackrock (17.07M shares, 13.04%), Vanguard group (11.75M shares, 8.97%), and Brown capital management (11.39M shares, 8.70%). Together, they hold 30.71% of Cytek Biosciences’s total shares outstanding.

Does Blackrock own Cytek Biosciences?

Yes, BlackRock owns 13.04% of Cytek Biosciences, totaling 17.07M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 95.25M$. In the last quarter, BlackRock decreased its holdings by -356K shares, a -2.04% change.

Who is Cytek Biosciences’s biggest shareholder by percentage of total assets invested?

Brown capital management is Cytek Biosciences’s biggest shareholder by percentage of total assets invested, with 1.28% of its assets in 11.39M Cytek Biosciences shares, valued at 63.54M$.

Who is the top mutual fund holder of Cytek Biosciences shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Cytek Biosciences shares, with 5.29% of its total shares outstanding invested in 6.82M Cytek Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools